NCT07157774: Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a)
- State
- Under way
- Phase
- Phase 3
- People
- 10,450 planned
- Started
- 2 Sep 2025
- Primary completion
- Mar 2031
- Arms
- Muvalaplin
- Results
- None posted
- 2 Sep 2025: Trial started
- 5 Sep 2025: Trial registered